Treating HER2-mutant advanced biliary tract cancer with neratinib
Dr James Harding - Memorial Sloan kettering Cancer Center, New York, USA
15 Jul 2019
Latest advances in pancreatic cancer treatment and impact on practice
Prof Eric Van Cutsem and Dr Talia Golan
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
24 Jun 2019
Comment: POLO III trial for metastatic pancreatic cancer
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
24 Jun 2019
Comment: Laparoscopic versus open resection for colorectal liver metastases
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
13 Jun 2019
ABC-06 results: Second-line ASC mFOLFOX chemotherapy for biliary tract cancer
Dr Angela Lamarca - The Christie NHS Foundation Trust, Manchester, UK
11 Jun 2019
Managing metastatic breast cancer and beyond using PARP inhibitors
Dr Harold Burstein - Dana-Farber Cancer Institute, Boston, USA
11 Jun 2019
POLO Trial: Olaparib as a maintenance treatment following first-line chemotherap...
Dr Teresa Macarulla - Vall d’Hebron Barcelona University Hospital, Barcelona, Sp...
6 Jun 2019
Highlights from ASCO 2019
Asst. Prof Bishal Gyawali and Monique Biryiana
3 Jun 2019
PARP inhibitor olaparib as treatment for pancreatic cancer patients with BRCA ge...
Dr Hedy Kindler - University of Chicago, Chicago, USA
2 Jun 2019
Maintenance therapy with PARP inhibitor olaparib delays progression in patients ...
Dr Hedy Kindler - University of Chicago, Chicago, USA
2 Jun 2019
Comment: It is essential to identify the BRCA gene in pancreatic cancer patients...
Dr Suzanne Cole - UT Southwestern Medical Center, Dallas, USA
2 Jun 2019
